AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Sales | 40,685 | 0 | 0 |
| Gross Profit | 40,685 | N/A | N/A |
| Operating Expenses | 21,301 | 0 | 0 |
| Operating Income | 19,384 | N/A | N/A |
| Interest Expense | 27 | 0 | 0 |
| Other Income | 1,740 | 0 | 0 |
| Pre-tax Income | 21,097 | 0 | 0 |
| Net Income Continuous | 21,097 | N/A | N/A |
| Net Income | $21,097 | $N/A | $N/A |
| EPS Basic Total Ops | 0.49 | N/A | N/A |
| EPS Basic Continuous Ops | 0.49 | N/A | N/A |
| EPS Diluted Total Ops | 0.46 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.46 | N/A | N/A |
| EBITDA(a) | $19,683 | $N/A | $N/A |